Comerica Bank’s Genmab GMAB Stock Holding History
Bought
Maintained
Sold
Other funds holding GMAB
Comerica Bank's GMAB Position: Q4 2022 in Review
Comerica Bank reduced its Genmab (GMAB) stake by 4.4% in Q4 2022, selling an estimated $38.9K and leaving 20,285 shares worth $812K. The position accounts for 0.01% of the portfolio, ranked #1569.
Comerica Bank first reported a position in GMAB in Q3 2019 and has held it in 14 quarters since. The position peaked at $2.03M in Q2 2021. 237 funds tracked by Wall St. Rank hold GMAB as of Q4 2022.
- Comerica Bank held 20,285 shares of Genmab worth $812K as of Q4 2022.
- Comerica Bank sold 943 Genmab shares in Q4 2022, an estimated $38.9K.
- Genmab made up 0.01% of Comerica Bank's portfolio in Q4 2022, its #1569 holding.
- Comerica Bank first reported a position in Genmab in Q3 2019 and has held it in 14 quarters since.
- Comerica Bank's Genmab position peaked at $2.03M in Q2 2021.
- 237 funds tracked by Wall St. Rank held Genmab as of Q4 2022.
Based on Comerica Bank's 13F filing for Q4 2022, filed 26 Jan 2023.